Published in Hospital Business Week, May 16th, 2004
HBeAg-negative hepatitis B is a mutant strain of the hepatitis B virus that lacks the ability to produce the "e" antigen. In this study, patients treated with Hepsera showed progressive reductions in serum HBV DNA replication and sustained alanine aminotransferase (ALT) normalization through 144 weeks of treatment. The development of Hepsera-related...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.